Tag Archives: Patients

FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma

Print this page KENILWORTH, N.J.–(BUSINESS WIRE) December 19, 2018 –Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma (MCC), based… Read More »

OIG: 46% of Medicare patients in LTC hospitals hit by adverse or harm events

Nearly half of Medicare patients in long-term care hospitals experienced adverse or temporary harm events during their stays. That’s among the findings of the HHS Office of Inspector General, which conducted a two-stage medical record review using physician reviewers to identify adverse events and temporary harm events in the sampled records. One in five Medicare… Read More »

Clinical trial will explore how Sensoria's smart socks can help Parkinson's patients

Smart sock maker Sensoria is teaming up with the Michael J. Fox Foundation and independent research group Neuroscience Research Australia to launch a 100-patient clinical trial looking at what smart textiles in socks can do for Parkinson’s disease patients. The trial, called Standing Tall-PD, is supported by a grant from MJFF. The first part of… Read More »